Web Toolbar by Wibiya
Login | Sign Up AnonymousUser
twiter
New to Comunitee?


or Sign Up with Email

Health

>> HYPERACTIVITY Latest News

APR 29, 2016 - Yahoo! News

A Must Read - Share

Shire jumps as Vyvanse drug helps it to beat earnings forecast

By Ben Hirschler LONDON (Reuters) - Strong demand for Shire's top-selling Vyvanse drug helped to lift first-quarter earnings by a better than expected 12 percent, boosting the London-listed group's shares ahead of its $32 billion acquisition of U.S. rare diseases specialist Baxalta . Sales of Vyvanse, a treatment for attention deficit hyperactivity disorder (ADHD), rose 22 percent, partly reflecting the ...

Tags: Shire jumps as Vyvanse drug helps it to beat earnings forecast,  Hyperactivity Latest News

APR 29, 2016 - Yahoo! News

A Must Read - Share

Shire earnings rise on strong Vyvanse demand

LONDON (Reuters) - Strong demand for hyperactivity treatment Vyvanse helped lift first-quarter earnings 12 percent at Shire , the London-listed drugmaker that is buying U.S. rare diseases firm Baxalta for $32 billion. Quarterly non-GAAP earnings per share of $3.19 on revenue up 17 percent to $1.71 billion compared with analysts' consensus forecasts of $3.05 and $1.69 billion, respectively, the company ...

Tags: Shire earnings rise on strong Vyvanse demand,  Hyperactivity Latest News